4. Risk
•MS is 3 times more common in women
•In the general population 1/330 people
get MS
•If you have ms, 1/67 chance your child will
get it
•Sibling risk 1/37
•Identical twin 1/4
5. Risk: Perspective
•MS risk in context
•1 in 3 people will develop some form of
cancer
•1 in 9 women will develop breast cancer
at some point in their lives
•1 in 22 people have chronic heart disease
•1 in 33 people have diabetes
•1 in 500 people have Parkinson's Disease
6. MS and Menses
•70% of females with MS report symptoms
may occur within one week of period
•Fatigue
•Depression
•Weakness
•Imbalance
7. Effects of MS on
fertility
There is no evidence that MS impairs fertility
or leads to an increased number of
spontaneous abortions, stillbirths or
congenital malformations. Several studies of
large numbers of women have repeatedly
demonstrated that pregnancy, labor, delivery
and the incidence of fetal complications are
no different in women who have MS than in
control groups without the disease.
8. Effects of pregnancy on MS
Before 1950, most women with MS were
counseled to avoid pregnancy because of the
belief that it might make their MS worse. Over
the past 40 years, many studies have been done in
hundreds of women with MS, and they have almost
all reached the opposite conclusion:
that pregnancy reduces the number of MS relapses,
especially in the second and third trimesters.
9. Effects in the postpartum period
Relapse rates tend to rise in the first three
to six months postpartum, and the risk of a relapse
in the postpartum period is estimated to be 20-40%.
These relapses do not appear to contribute to increased
long-term disability. In the studies
with long-term follow-up
of women with MS who had children, no increased
disability as a result of pregnancy was found.
Pregnancy is known to be associated with an increase
in a number of circulating proteins and other factors that
are natural immunosuppressants. Additionally,
levels of natural corticosteroids are higher in pregnant
than nonpregnant women.
10. Cervical Screening
•All women should begin cervical cancer
testing at age 21. Women aged 21 to 29,
should have a Pap test every 3 years. HPV
testing should not be used for screening in
this age group (it may be used as a part of
follow-up for an abnormal Pap test).
•Beginning at age 30, the preferred way to
screen is with a Pap test combined with an
HPV test every 5 years. This is called co-
testing and should continue until age 65.
11.
12. Cervical Screening (cont.)
If over 65 years of age who have had
regular screening in the previous 10 years
should stop cervical cancer screening as
long as they haven’t had any serious pre-
cancers (like CIN2 or CIN3) found in the
last 20 years. Women with a history of
CIN2 or CIN3 should continue to have
testing for at least 20 years after the
abnormality was found.
13. Cervical Screening (cont.)
•Another reasonable option for women 30 to
65 is to get tested every 3 years with just the
Pap test.
•Women who are at high risk of cervical
cancer because of a suppressed immune
system or because they were exposed to DES
in utero may need to be screened more
often. They should follow the
recommendations of their health care team.
14. Cervical Screening (cont.)
•Women who have had a total hysterectomy
should stop screening (such as Pap tests and
HPV tests), unless the hysterectomy was
done as a treatment for cervical pre-cancer
(or cancer).
•Women of any age should NOT be screened
every year by any screening method
•Women who have been vaccinated against
HPV should still follow these guidelines.
15.
16. Mammograms
•Recommendations for early breast cancer detection
in women without breast symptoms
•Women in their 20s and 30s should have a clinical
breast exam (CBE) as part of a periodic (regular)
health exam by a health professional preferably
every 3 years.
•Starting at age 40, women should have a CBE by a
health professional every year.
•Women age 40 and older should have a
mammogram every year and should continue to do
so for as long as they are in good health.
17. Other imaging:
•Women who are at high risk for breast
cancer based on certain factors should
get an MRI and a mammogram every
year.
18. Bone Density Scan:
Start before age 60
if at risk;
risk factors include steroid use,
family history,
lack of exercise, alcohol use,
thin body, and smoking.
19.
20. Mammograms (cont.)
•How can uninsured or low-income
women obtain a free or low-cost
screening mammogram?
•Go to CDC website or by calling 1–800–
CDC–INFO (1–800–232–4636).
•
23. Hot Flashes
Hot flashes
■ Lifestyle changes. These include dressing
and eating
to avoid being too warm, sleeping in a cool
room, and
reducing stress. Avoid spicy foods and
caffeine. Try deep
breathing and stress reduction techniques,
including meditation
and other relaxation methods.
25. Treat Hot Flashes
• Vit E 400 IU a day
• Black cohosh- 20 mg twice a day Before using black cohosh, talk to your
healthcare provider. You may not be able to use black cohosh if you have certain
medical conditions, especially.
liver disease; past or present cancer of the breast, ovary, or uterus; a history of
endometriosis or uterine fibroids; a genetic blood-clotting disorder; or if you have ever
had a kidney transplant.
• Black cohosh can harm your liver. Stop using if you get yellow skin or dark urine
• Common side effects may include:
• stomach pain or upset;
• heavy feeling;
• vaginal bleeding or spotting;
• headache;
• rash; or
• weight gain.
26. Estrogen Replacement
•54% of female MS individuals reported that
their symptoms became worse with
menopause and 75% of those who had tried
HRT said it had helped reduce their
symptoms.
Further research is warranted in this area,
particularly given the recent findings from
the Women's Health Study that the overall
risks of HRT may outweigh the benefits for all
women
27. Mammograms
•What is the best method of detecting breast
cancer as early as possible?
•Getting a high-quality screening mammogram
and having a clinical breast exam on a regular
basis are the most effective ways to detect
breast cancer early.
•Regularly checking one’s own breasts for lumps
cannot replace regular screening mammograms
or clinical breast exams. In clinical trials, self
exam alone was not found to help reduce the
number of deaths from breast cancer.
•
28.
29. MS and Vaccinations
•Safe: flu, hepatitis B, varicella and tetanus
vaccines
• Inactivated vaccines are generally
considered safe for people with MS, including
those who are taking an interferon
medication (Avonex®, Betaseron®, Extavia®,
Plegridy™, Rebif®), Aubagio®, Copaxone®,
Gilenya®, Glatopa®, Lemtrada®, Novantrone,
Tecfidera® or Tysabri®.
30. Flu vaccine
•Takes 2 weeks to work
•May lower the risk of getting the flu by
70-90%
•36,000 people a year die from the flu
•Talk to your doctor
31. These Increase Risk for Flu
Complications
• asthma
• Neurological and neurodevelopmental conditions [including disorders of
the brain, spinal cord, peripheral nerve, and muscle such as cerebral palsy,
epilepsy (seizure disorders), stroke, intellectual disability (mental
retardation), moderate to severe developmental delay, muscular
dystrophy, or spinal cord injury].
• Chronic lung disease
• Heart disease
• Blood disorders (such as sickle cell disease)
• diabetes
• Kidney disorders
• Liver disorders
• Metabolic disorders (such as inherited metabolic disorders and
mitochondrial disorders)
• Weakened immune system due to disease or medication (such as people
with HIV or cancer, or those on chronic steroids)
32. Vaccinations
• If you had a recent relapse: defer vaccination until 4-6 weeks
• Live, attenuated vaccines are generally not recommended
for a person with.
• People on therapies that suppress the immune system,
such as Cytoxan, Imuran®, Novantrone, Rheumatrex®
and/or chronic corticosteroid therapy, should consult their
neurologist before taking any live-virus vaccine.
• A person should not receive a live-virus vaccine following a
course of Lemtrada™.
• MS experts are not in agreement about the risks for a
person with MS whose close family member receives a live-
virus vaccine. The family should discuss with the
neurologist how best to handle this situation.
33. Varicella (chicken pox) vaccine?
•This vaccine should be considered by people
with MS who have never had chicken pox,
lack evidence of prior immunity, and are
considering starting an MS medication that
has the potential to suppress cell mediated
immunity – for example, Gilenya®
(fingolimod) and Lemtrada™ (alemtuzumab).
• The vaccine should be taken six weeks
before starting the MS therapy.
34. Shingles vaccine (Zostavax®).
A live-virus
vaccine to prevent shingles.
I do not
recommend live-virus vaccines for
people with MS because these vaccines can
lead to an increase in disease activity.
However !!!
Zostavax is an exception because most people
have had chicken pox earlier in their lives and
therefore already have the virus
in their bodies.
.
35.
36. Calcium
recommendations
•General — Premenopausal women and
men should consume at least 1000 mg/d
of calcium, while postmenopausal
women should consume 1200 mg/d (total
diet plus supplement).
•Calcium carbonate is effective and is the
least expensive form of calcium
•Obtain some or all from the diet
37. Calcium (cont.)
•●Calcium supplements do not replace other
osteoporosis treatments such as hormone
replacement, bisphosphonates (eg, risedronate
[Actonel] and alendronate [Fosamax]), and
raloxifene: Evista).
• Calcium in the diet — The primary sources of
calcium in the diet include milk and other dairy
products, such as hard cheese, cottage cheese,
or yogurt, as well as green vegetables, such as
kale and broccoli. Some cereals, soy products,
and fruit juices are fortified with calcium.
38. CAM and MS
•AAN guideline Feb 2014
•Knowledgeable advice should be
given by doctor
•Counseling is part of the evaluation
and management
39. Complementary Alternative
Medicine
•Gingko biloba- NOT helpful for cognition
but probably helpful for fatigue
•Reflexology Possibly effective for MS
paresthesia
•Vit D-may decrease exacerbations (5000
IU daily)
•Cigarette smoking increases progression
in MS
•Cannabis-probably effective for pain and
possibly effective for spasticity
•Magnet therapy
• Pulsed magnetic fields probably effective for decreasing MS fatigue
44. Pain relief for the 21st Century
Pulsed Electro-Magnetic Field Therapy
(PEMF) is a completely safe, non-invasive
pain relief system that has absolutely no side
effects. It works to relieve pain by producing
a magnetic field that is 10,000 times more
powerful than a standard magnet.
Research has shown that PEMF Therapy can
result in Neurological, Physiological and
Psychological benefits. By inducing electrical
charges within cells, PEMF could restore the
painful area to its normal healthy state.
The results are less pain, reduced swelling
and inflammation, and increased range of
motion. Take control of your health. Please
call 808-732-5363 to schedule your
appointment today.
45. Probiotics in MS?
•Live microorganisms
•In adequate amounts give you a health
benefit
•Developed in a lab put in pills, powder,
yogurt, drinks or food
•When probiotics are present in your gut
they act like peacekeepers (restore
order)
46. How Do Probiotics Work?
•Take up temporary residence
•Improve the gut barrier
•Probiotics may tighter the bond between
the cells and stimulate mucus production
•Suppress harmful bacteria
47. Probiotics (cont.)
•The gut houses more nerve endings than
any where else in your body besides the
brain
•Prebiotics –what is the difference?
• Are not bacteria
Naturally occurring soluble fibers
bananas oatmeal beans
----------------------------------------------------------------------------------------------------------------------------------
Dietary Sources probiotics:
Kombucha (fermented tea) raw sauerkraut yogurt kefir and kimchi
48.
49. Probiotic supplement (containing
Lactobacillus acidophilus):
5 to 10 billion CFUs (colony forming units)
a day, for maintenance of
gastrointestinal and immune
health. While probiotics may be helpful
for people with
MS, they may not be appropriate for
individuals who are severely
immunosuppressed or who are on
immunosuppressive drugs.
50. Progressive Multifocal
Leukoencephalopathy
•If you are on Tysabri (450 cases), Gilenya
(3 ), Rituxan, Tecfidera(3) or Lemtrada ( 1)
be wary of this
•Can seem like a relapse
•Rare in first yr of treatment
•May have behavioral changes
•Know your JC antibody status
51. Review
•Cervical cancer screening every 5 years
•Mammogram every yr starting age 40
•Know your JC antibody status (a blood
test)
•Consider getting the flu shot
•Hot flashes ? Black cohosh 20 mg twice a
day to start
•Probiotics may help bowel issues in MS
52. Helpful Resources
Center for Research on Women with
Disabilities
(800) 442-7693
Chronic Illness Coach
(617) 969-1930
Dating 4 Disabled
www.datingfordisabled.com or (201) 984-
9230
Dress for Success
www.dressforsuccess.org or (212) 532-1922
(Provides professional attire, support, and
career development to disadvantaged
women)
National Domestic Violence Hotline
www.ndvh.org
or (800) 799-SAFE (7233)
National Women's Health Information
Center
1 (800) 994-9662
Hinweis der Redaktion
How does it work?
The root of black cohosh is used for medicinal purposes. Black cohosh root contains several chemicals that might have effects in the body. Some of these chemicals work on the immune system and might affect the body’s defenses against diseases. Some might help the body to reduce inflammation. Other chemicals in black cohosh root might work in nerves and in the brain. These chemicals might work similar to another chemical in the brain called serotonin. Scientists call this type of chemical a neurotransmitter because it helps the brain send messages to other parts of the body.Black cohosh root also seems to have some effects similar to the female hormone, estrogen. In some parts of the body, black cohosh might increase the effects of estrogen. In other parts of the body, black cohosh might decrease the effects of estrogen. Estrogen itself has various effects in different parts of the body. Estrogen also has different effects in people at different stages of life. Black cohosh should not be thought of as an “herbal estrogen” or a substitute for estrogen. It is more accurate to think of it as an herb that acts similar to estrogen in some people.
When detected at its earliest stage there is a 91 survivial rate
Women who are at high risk for breast cancer based on certain factors should get an MRI and a mammogram every year.
This includes women who:
Have a lifetime risk of breast cancer of about 20% to 25% or greater, according to risk assessment tools that are based mainly on family history (such as the Claus model - see below)
Have a known BRCA1 or BRCA2 gene mutation
Have a first-degree relative (parent, brother, sister, or child) with a BRCA1 or BRCA2 gene mutation, and have not had genetic testing themselves
Had radiation therapy to the chest when they were between the ages of 10 and 30 years
Have Li-Fraumeni syndrome, Cowden syndrome, or Bannayan-Riley-Ruvalcaba syndrome, or have first-degree relatives with one of these syndromes
What is 3D mammography?
Three-dimensional (3D) mammography, also known as breast tomosynthesis, is a type of digital mammography in which x-ray machines are used to take pictures of thin slices of the breast from different angles and computer software is used to reconstruct an image. This process is similar to how a computed tomography (CT) scanner produces images of structures inside of the body. 3D mammography uses very low dose x-rays, but, because it is generally performed at the same time as standard two-dimensional (2D) digital mammography, the radiation dose is slightly higher than that of standard mammography. The accuracy of 3D mammography has not been compared with that of 2D mammography in randomized studies. Therefore, researchers do not know whether 3D mammography is better or worse than standard mammography at avoiding false-positive results and identifying early cancers.
Menopausal hormone therapy once seemed the answer for many of the conditions women face as they age. It was thought that hormone therapy could ward off heart disease, osteoporosis, and cancer, while improving women’s quality of life. But beginning in July 2002, findings emerged from clinical trials that showed this was not so. In fact, long-term use of hormone therapy poses serious risks and may increase the risk of heart attack and stroke.T
CALCIUM AND VITAMIN D BENEFITS
Good nutrition is important at all ages to keep the bones healthy.
●Taking calcium reduces bone loss and decreases the risk of fracturing the vertebrae (the bones that surround the spinal cord).
●Consuming calcium during childhood (eg, in milk) can lead to higher bone mass in adulthood. This increase in bone density can reduce the risk of fractures later in life.
●Calcium may also have benefits in other body systems by reducing blood pressure and cholesterol levels.
●Calcium and vitamin D supplements may help prevent tooth loss in older adults.
Side effects of calcium — Calcium is usually easily tolerated when it is taken in divided doses several times per day. Some people experience side effects related to calcium, including constipation and indigestion. Calcium supplements interfere with the absorption of iron and thyroid hormone and, therefore, these medications should be taken at different times.
Kidney stones — There is little evidence that consuming large amounts of calcium (from foods and drinks) increases the risk of kidney stones, or that avoiding dietary calcium decreases the risk. In fact, avoiding dairy products is likely to increase the risk of kidney stones.
However, use of calcium supplements may increase the risk of kidney stones in susceptible individuals by raising the level of calcium in the urine. This is particularly true if the supplement is taken between meals or at bedtime. (See "Patient information: Kidney stones in adults (Beyond the Basics)".)
The Wellness Center
Many have gi issues
These could switch you in the right direction
It requires 5 days of habitual ingestion for probiotics to build up a presence
Probiotics are smart
Some of the sam ones that help with diarrhea may help with constipation
we think they go in figure out what is needed and then upregulate or downregulate your immune response
Most pathogen don’t want to do harm
They just want to eat and hang out maybe they just prevent the toxin release from a bacteria
The GI have an ultra thin one cell later barrie
Prebiotics are special bc they do not get digested until they reach the colon
Also oatmeal beans asparagus for prebiotics
Magic words for yogurt and kefir are live acive cultures (no more than 12 g sugar per serving
Take 2 hours after antibiotic
Described first in 1958-Hodgkins pt
JCV enter the brain and cause PML or whether the protein shell evolves when virus already in the brain goes wild in the absence of T cells.
“We know these mutations occur,” said Robert Garcea, MD, a virologist and pediatric oncologist at the University of Colorado, Boulder, U.S. “We don’t know if they are a cause or effect” of PML. Garcea is on the scientific advisory board of the PML Consortium and was not involved in the new studies. “These papers cause a lot of excitement about developing therapies or prophylactic vaccines for the side effects of wonderful drugs,” he told MSDF.
Atwood welcomes the new therapeutic strategy proposed by the papers, but he doesn’t think they answer key questions about how JCV causes PML. “We don’t think mutants are driving the disease, we think the disease is driving the mutants,” he told MSDF. The mutants may contribute to the spread of disease in the brain, but they are not required for PML, he said.
The active and passive vaccination discoveries are protected by patents. From Martin’s group, the monoclonal antibody approach used in the passive vaccination is under a patent licensed by the University of Zurich to Neurimmune, a small biotechnology company near Zurich. The active vaccination patent based on Martin’s earlier study has been licensed to Neuway Pharma Bonn, a biotech startup in Germany.
NCI has applied for a patent on the VLP vaccine technology and is engaged in cooperative research and development agreements with MedImmune, the biologics research and development arm of AstraZeneca, a British-Swedish company headquartered in London, and with Biogen of Cambridge, Massachusetts.
Despite the interest of drug companies in preventing PML, the disease is so rare that they may hesitate to launch an expensive clinical trial, several experts told MSDF.
The authors, however, are optimistic about the prospects for preventing or treating the devastating disease. So far, nothing else is out there. “Everything that has been tried so far has failed,” Martin said. Buck and Pastrana trained in the labs of scientists who developed the HPV vaccine. In a take-home lesson for Buck, “they had to figure out how to assemble the vaccine, and then they had to figure out how to get companies to make it.”
PML emerges on scene
The first report of PML in 1958 described a brain disease with scattered demyelination in three people with Hodgkin’s lymphoma. The viral cause of PML was discovered in 1971 and named JC virus (JCV) for the patient’s initials. PML surged onto the scene in the early days of HIV, when PML became a common and severe opportunistic infection. It was a virtual death sentence for about 5 percent of all people with untreated HIV, which depletes a major type of T cells. Now, antiretroviral therapy has greatly decreased PML cases, but HIV still accounts for the vast majority of deaths due to PML (Gheuens et al.,2013).
Then came a surprise. A 2005 report linked PML with monoclonal antibody therapy, specifically natalizumab (Tysabri), in two people with MS and one with Crohn’s disease. Natalizumab blocks a receptor on T cells and prevents them from crossing from the blood into the brain. The drug was withdrawn from the market for one year. Another PML-associated therapy for psoriasis, efalizumab (Raptiva), was removed from the market in 2009.
Natalizumab disproportionately predisposes people to PML, said Joseph Berger of the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, U.S., in anApril 21, 2015, MSDF podcast. Several other MS drugs carry a lower risk of PML, including dimethyl fumarate (Tecfidera), alemtuzumab (Lemtrada), and fingolimod(Gilenya), as well as rituximab (Rituxan), an anti-CD20 antibody targeting B cells that is also used for hematological and other autoimmune diseases.
PML prevention now relies mainly on prescreening high-risk patients and prescribing natalizumab for only a limited time, as well as close monitoring of people on any drug associated with PML. About three-quarters of people with natalizumab-associated PML have survived the illness, often with irreversible brain damage and disability (Berger, 2015).
Key open questions
Will a broadly neutralizing JCV VLP vaccine prevent PML in people?
Will antibodies engineered from memory B cells of PML survivors be effective in treating PML?
How will the clinical trials be designed to evaluate safety and effectiveness of such a rare disease?
How does the virus get into the brain? Is it there all along from an early childhood infection? Does the virus replicate somewhere else and acquire mutations that allow it to get into the brain?
What is the role of mutated JCV in PML? About 3 weeks ago, Biogen learned of a 3rd case of PML in a relapsing-remitting MS patient on Tecfidera. This patient, like the 2 previous Tecfidera PML cases, had lab-confirmed prolonged (ca 1 year) severe (<500 cells/ul) lymphopenia. The label recommends testing for lymphocyte counts and considering discontinuation in the setting on lymphopenia. However, despite confirmed lymphopenia for at least a year, this patient remained on Tecfidera. The patient is currently stable.
Globally, over 162K patients have been exposed to Tecfidera, with 157K patient years of exposure. There have been no other safety signals—no increases in opportunistic infections. This makes the third case of PML in a patient with documented prolonged, severe lymphopenia.